Anavex Life Sciences (AVXL) Return on Capital Employed Growth (3y) (2020 - 2022)
Anavex Life Sciences (AVXL) Return on Capital Employed Growth (3y) (2020 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 4,853.00 |
| 10 | Anavex Life Sciences | 223.40 Mn | 91.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 14,928.00 |
| Mar 31, 2022 | 30,213.00 |
| Dec 31, 2021 | 36,559.00 |
| Sep 30, 2021 | 34,958.00 |
| Mar 31, 2021 | 28,655.00 |
| Dec 31, 2020 | 11,888.00 |
| Sep 30, 2020 | 8,254.00 |